Literature DB >> 29614894

Management of fetal growth restriction using the contraction stress test: a case-control study.

Hiroaki Tanaka1, Fumi H Furuhashi1, Kuniaki Toriyabe1, Takeshi Matsumoto1, Shoich Magawa1, Masafumi Nii1, Junko Watanabe1, Kayo Tanaka1, Takashi Umekawa1, Yuki Kamimoto1, Tomoaki Ikeda1.   

Abstract

Purpose: Fetal growth restriction (FGR) is a concerning health issue. However, studies on FGR management are limited due to its rarity. We aimed to evaluate the efficacy of the contraction stress test (CST) for FGR management. Materials and methods: A case-control retrospective study design. Our institute innovated CST in FGR management in 2017. We included women in their 33rd-40th week of pregnancy with a diagnosis of FGR and retrospectively divided them into groups: the CST group (FGR management with CST) and no CST group (FGR management without CST) before and after CST development. Neonatal outcome, pH, and pO2 of umbilical artery (UA) were compared between the two groups.
Results: No significant differences in the rate of birth weight, Apgar score <7 (5 minutes), neonatal death, hospitalization to newborn childhood intensive care unit (NICU), and UA pH were found between groups. Average UA pH was 7.29 ± 0.05 and 7.29 ± 0.04 in the CST and no CST groups, respectively (p = .864). Average UA pO2 values were 21.1 ± 8.6 and 15.7 ± 5.0 mmHg in the CST and no CST groups, respectively (p = .016), showing significant differences. Conclusions: Neonatal outcomes and UA pH were slightly different between the groups managed with and without CST. However, UA pO2 values significantly differed between the groups. For FGR management, the use of a CST may allow for early intervention before fetal acidemia and acidosis. For establishing the effects of a CST for FGR management, analysis including several cases and investigation of long-term outcomes of newborn infants is necessary.

Entities:  

Keywords:  Fetal growth restriction; contraction stress test; hypoxemia; maternal complications; neonatal outcome; pregnancy

Mesh:

Substances:

Year:  2018        PMID: 29614894     DOI: 10.1080/14767058.2018.1461313

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  2 in total

1.  The Application Value of Three-Dimensional Power Doppler Ultrasound in Fetal Growth Restriction.

Authors:  Yanju Wang; Lihua Liang; Yingfeng Liu; Peipei Li; Jie Ren
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-16       Impact factor: 2.650

2.  The Present Utility of the Oxytocin Challenge Test-A Single-Center Study.

Authors:  Anna Różańska-Walędziak; Krzysztof Czajkowski; Maciej Walędziak; Justyna Teliga-Czajkowska
Journal:  J Clin Med       Date:  2020-01-03       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.